Notable Analyst rating Changes for 02/05: RMD, WFR, ALKS, SFN, BEBE Upgraded; FWD, EGOV, LEAP, COH, CIEN Downgraded
Tweet Send to a Friend
UPGRADES
Wells Fargo upgrades ResMed Inc. (NYSE: RMD) from Underperform to Market Perform. Valuation range increased from $45-47 to $53-58 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo upgrades ResMed Inc. (NYSE: RMD) from Underperform to Market Perform. Valuation range increased from $45-47 to $53-58 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
